Olivier Terrier

International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)

Université de Lyon - Université Claude Bernard Lyon 1

Lyon, 69008

France

  • Université de Lyon - Université Claude Bernard Lyon 1

SCHOLARLY PAPERS

3

DOWNLOADS

139

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Host-Directed Repurposed Diltiazem Enhances the Antiviral Activity of Classic Antivirals Against Influenza and Sars-Cov-2

Number of pages: 36 Posted: 10 Dec 2024
Blandine Padey, Clément Droillard, Victoria Dulière, Julien Fouret, Claire Nicolas de Lamballerie, Cédrine Milesi, Emilie Laurent, Pauline Brun, Aurélien Traversier, Thomas Julien, Olivier Terrier, Manuel Rosa-Calatrava and Andrés Pizzorno
affiliation not provided to SSRN, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université de Lyon - Université Claude Bernard Lyon 1, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada) and International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)
Downloads 52 (835,331)

Abstract:

Loading...

diltiazem, host-directed antivirals, drug combination, Respiratory Viruses, Influenza, SARS-COV-2

2.

Critical COVID-19 Unveils the Link between Viral Particle Blood Dissemination and Prolonged Type I Interferon

Number of pages: 44 Posted: 08 May 2024
Kahina Saker, Marine Mommert, Guy Oriol, Laurence Generenaz, Valérie Cheynet, Antonin Bal, Paul Bastard, Jean Laurent Casanova, Emmanuel Roux, Karen Brengel-Pesce, Aurore Fleurie, Sylvie Pons, Cécile Barnel, Bouchra Mokdad, Florent Wallet, Olivier Terrier, Jean-Christophe Richard and Sophie Assant
Hospices Civils de Lyon - Laboratoire de Virologie, Lyon Sud Hospital, Lyon Sud Hospital, Lyon Sud Hospital, Lyon Sud Hospital, Hospices Civils de Lyon - Laboratoire de Virologie, University of Paris - Laboratory of Human Genetics of Infectious Diseases, University of Paris - Laboratory of Human Genetics of Infectious Diseases, Université Lyon 1, Lyon Sud Hospital - Joint Research Unit Civils Hospices of Lyon-bioMérieux, Lyon Sud Hospital, Lyon Sud Hospital, Hospices Civils de Lyon, Hospices Civils de Lyon - Laboratoire de Virologie, Hospices Civils de Lyon - Medical Intensive Care Unit, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Hospices Civils de Lyon - Service de Médecine Intensive-Réanimation and Hospices Civils de Lyon - Laboratoire de Virologie
Downloads 52 (835,331)

Abstract:

Loading...

SARS-CoV-2, type I IFN, N-antigenemia, critical illness, innate immune response

3.

New Mucosal Bivalent Live-Attenuated Vaccine is Protective Against Human Metapneumovirus and Respiratory Syncytial Virus

Number of pages: 48 Posted: 06 Jul 2023
Daniela Ogonczyk-Makowska, Clémence Vacher, Andrés Pizzorno, Pauline Brun, Caroline Chupin, Clément Droillard, Julie Carbonneau, Emilie Laurent, Victoria Duliere, Aurélien Traversier, Olivier Terrier, Thomas Julien, Marie Galloux, Stephane Paul, Jean-Francois Eleouet, Marie-Ève Hamelin, Guy Boivin, Manuel Rosa-Calatrava and Julia Dubois
Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université Laval- Infectious Disease Research Centre, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada), Université de Lyon - Université Claude Bernard Lyon 1, University of Paris-Saclay - UVSQ, VIM, University of Claude Bernard Lyon 1 - CIRI, University of Paris-Saclay - UVSQ, VIM, Université Laval- Infectious Disease Research Centre, Centre de Recherche en Infectiologie of the Centre Hospitalier Universitaire de Québec and Université Laval, International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada) and International Associated Laboratory RespiVir (LIA VirPath-LVCM France-Canada)
Downloads 35 (988,303)

Abstract:

Loading...

RSV, HMPV, chimeric virus, bivalent vaccine, live attenuated vaccine, vectored vaccine, reverse genetics, gene insertion, respiratory viruses, pneumovirus, bronchiolitis